US Tech 100

18,850.00

0.50%

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
USA
AMEX
AIM ImmunoTech Inc (AIM)
AIM ImmunoTech Inc (AIM) News

AIM

AIM ImmunoTech (AIM)

AIM ImmunoTech Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:AIM

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
03/27/2025	8:05AM	GlobeNewswire Inc.	AIM ImmunoTech Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update	AMEX:AIM	AIM ImmunoTech Inc
03/27/2025	7:17AM	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	AMEX:AIM	AIM ImmunoTech Inc
03/18/2025	5:11PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:AIM	AIM ImmunoTech Inc
03/18/2025	5:10PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:AIM	AIM ImmunoTech Inc
03/18/2025	5:10PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:AIM	AIM ImmunoTech Inc
03/11/2025	8:45AM	GlobeNewswire Inc.	AIM ImmunoTech Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference	AMEX:AIM	AIM ImmunoTech Inc
03/06/2025	9:36AM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:AIM	AIM ImmunoTech Inc
03/05/2025	10:00AM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:AIM	AIM ImmunoTech Inc
03/04/2025	3:04PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:AIM	AIM ImmunoTech Inc
03/04/2025	2:17PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:AIM	AIM ImmunoTech Inc
03/04/2025	2:14PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:AIM	AIM ImmunoTech Inc
03/04/2025	1:14PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:AIM	AIM ImmunoTech Inc
02/28/2025	4:45PM	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	AMEX:AIM	AIM ImmunoTech Inc
02/28/2025	8:45AM	GlobeNewswire Inc.	AIM announces Paul Goepfert, MD, as the principal investigator for the planned clinical study of Ampligen and FluMist as a vaccine for avian influenza	AMEX:AIM	AIM ImmunoTech Inc
02/28/2025	8:00AM	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:AIM	AIM ImmunoTech Inc
02/26/2025	5:23PM	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	AMEX:AIM	AIM ImmunoTech Inc
02/26/2025	1:20PM	GlobeNewswire Inc.	AIM ImmunoTech Announces NYSE American Acceptance of Plan to Regain Listing Compliance	AMEX:AIM	AIM ImmunoTech Inc
02/26/2025	8:45AM	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:AIM	AIM ImmunoTech Inc
02/26/2025	8:30AM	GlobeNewswire Inc.	AIM ImmunoTech Appoints David Chemerow to Board of Directors as an Independent Director	AMEX:AIM	AIM ImmunoTech Inc
02/25/2025	8:30AM	GlobeNewswire Inc.	AIM Doses First New Subject in Phase 2 Study of Ampligen and Imfinzi as a Potential Combination Therapy for Late-Stage Pancreatic Cancer	AMEX:AIM	AIM ImmunoTech Inc
02/20/2025	4:52PM	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	AMEX:AIM	AIM ImmunoTech Inc
02/20/2025	4:52PM	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	AMEX:AIM	AIM ImmunoTech Inc
02/20/2025	4:52PM	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	AMEX:AIM	AIM ImmunoTech Inc
02/19/2025	4:20PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:AIM	AIM ImmunoTech Inc
02/19/2025	4:20PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:AIM	AIM ImmunoTech Inc
02/14/2025	4:55PM	Edgar (US Regulatory)	Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	AMEX:AIM	AIM ImmunoTech Inc
02/11/2025	8:50AM	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:AIM	AIM ImmunoTech Inc
02/11/2025	8:45AM	GlobeNewswire Inc.	AIM ImmunoTech Releases Virtual Investor “What This Means Segment”	AMEX:AIM	AIM ImmunoTech Inc
02/11/2025	8:35AM	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:AIM	AIM ImmunoTech Inc
02/11/2025	8:30AM	GlobeNewswire Inc.	AIM ImmunoTech announces that it will not proceed with an offering pursuant to its Registration Statement on Form S-1 until after it files its Annual Report on Form 10-K for the fiscal year ended December 31, 2024	AMEX:AIM	AIM ImmunoTech Inc